Notice: ASA extends its thoughts and condolences to those affected by the disaster in Oklahoma. Donations to help aid this relief can be made through the American Red Cross website.

>

WEBINARS

RSS
>

MEETINGS / EVENTS

RSS
>

FDA MEDWATCH ALERTS

RSS

June 13, 2013

Symbios GOPump and GOBlock Kits: Class 1 Recall - Potential for Excessive High Flow Rates

Summary:

Symbios GOPump and GOBlock Kits Class 1 Recall

June 11, 2013

Vecuronium Bromide For Injection by Sagent Pharmaceuticals, Inc.: Recall - Elevated Impurity Result Detected

Summary:

Vecuronium Bromide For Injection by Sagent Pharmaceuticals Inc

June 10, 2013

Main Street Family Pharmacy in Tennessee: FDA Alerts Health Care Providers of Adverse Reactions Associated with Steroid Injections

Summary:

Main Street Family Pharmacy in Tennessee FDA Alerts Health Care Providers

>

ASA FEATURED PRODUCT

Add this product to your shopping cart

Anesthesiology Continuing Education (ACE) Program

SKU: 30702-13CE

... Read more »

Single Copies, Member Price: $360

CareFusion Airlife Infant Breathing Circuit: Class I Recall - Potential for Leak in Closed Ventilation System

Friday, July 06, 2012

AUDIENCE: Anesthesiology, Risk Manager

ISSUE: FDA notified healthcare professionals of the Class 1 recall of the Airlife infant breathing circuit due to the risk that the Y-adapter within the breathing circuit may spontaneously crack, causing a leak in the closed ventilation system. This leak could lead to a decrease in the tidal volume delivered to the ventilated patient. These products may cause serious adverse health consequences, including death. The recalled products were distributed from July 1, 2010 through May 7, 2012.

See the Recall Notice for a listing of affected lot numbers.

BACKGROUND: Respiratory breathing circuits are used with a ventilator when mechanical ventilation is administered to a patient.

RECOMMENDATION: On May 29, 2012, the firm sent an Urgent Recall Notice to customers and distributors. The distributors were requested to immediately destroy any affected product in-stock at their facilities and to cease distributing these products. They were also requested to forward the recall notice to any customers to whom these products were sold, notifying them of the potential risk. CareFusion is requesting that customers destroy all affected product or return any unused product to the distributor.

Read the MedWatch safety alert, including a link to the FDA Recall Notice, at:
http://www.fda.gov/Safety/MedWatch/SafetyInformation/SafetyAlertsforHumanMedicalProducts/ucm310871.htm

« Back to FDA Alerts and Recalls